Cargando…

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

Neurodegenerative diseases like Alzheimer’s, Parkinson’s and Huntington’s disease involves abnormal aggregation and accumulation of toxic proteins aggregates. Post-translational modifications (PTMs) of the causative proteins play an important role in the etiology of disease as they could either slow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balmik, Abhishek Ankur, Chinnathambi, Subashchandrabose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103764/ https://www.ncbi.nlm.nih.gov/pubmed/33962636 http://dx.doi.org/10.1186/s12964-021-00732-z

Ejemplares similares

Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia
por: Das, Rashmi, et al.
Publicado: (2020)

Melatonin Reduces GSK3β-Mediated Tau Phosphorylation, Enhances Nrf2 Nuclear Translocation and Anti-Inflammation
por: Das, Rashmi, et al.
Publicado: (2020)

The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau
por: Balmik, Abhishek Ankur, et al.
Publicado: (2021)

EGCG impedes human Tau aggregation and interacts with Tau
por: Sonawane, Shweta Kishor, et al.
Publicado: (2020)

Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6
por: Dangi, Abha, et al.
Publicado: (2020)

Correction: Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6
por: Dangi, Abha, et al.
Publicado: (2022)

Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease
por: Sonawane, Shweta Kishor, et al.
Publicado: (2019)

Photoexcited Toluidine Blue Inhibits Tau Aggregation in Alzheimer’s Disease
por: Dubey, Tushar, et al.
Publicado: (2019)

TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective
por: Kapoor, Mahima, et al.
Publicado: (2023)

G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-β in Alzheimer’s disease
por: Desale, Smita Eknath, et al.
Publicado: (2021)

Photodynamic exposure of Rose-Bengal inhibits Tau aggregation and modulates cytoskeletal network in neuronal cells
por: Dubey, Tushar, et al.
Publicado: (2020)

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation
por: Sonawane, Shweta Kishor, et al.
Publicado: (2021)

Author Correction: Photodynamic exposure of Rose-Bengal inhibits Tau aggregation and modulates cytoskeletal network in neuronal cells
por: Dubey, Tushar, et al.
Publicado: (2022)

Neem Derivatives Inhibits Tau Aggregation
por: Gorantla, Nalini V., et al.
Publicado: (2021)

Neem Derivatives Inhibits Tau Aggregation(1)
por: Gorantla, Nalini V., et al.
Publicado: (2019)

Role of dietary fatty acids in microglial polarization in Alzheimer’s disease
por: Desale, Smita Eknath, et al.
Publicado: (2020)

Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer’s disease
por: Desale, Smita Eknath, et al.
Publicado: (2021)

Molecular Cobalt(II) Complexes for Tau Polymerization in Alzheimer’s Disease
por: Gorantla, Nalini Vijay, et al.
Publicado: (2019)

Amyloid-β-Derived Peptidomimetics Inhibits Tau Aggregation
por: Gorantla, Nalini V., et al.
Publicado: (2021)

Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation
por: Chidambaram, Hariharakrishnan, et al.
Publicado: (2020)

α– Linolenic acid modulates phagocytosis and endosomal pathways of extracellular Tau in microglia
por: Desale, Smita Eknath, et al.
Publicado: (2021)

Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network
por: Sonawane, Shweta Kishor, et al.
Publicado: (2021)

α-Linolenic acid induces clearance of Tau seeds via Actin-remodeling in Microglia
por: Desale, Smita Eknath, et al.
Publicado: (2021)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020)

Microglia degrade Tau oligomers deposit via purinergic P2Y12-associated podosome and filopodia formation and induce chemotaxis
por: Chinnathambi, Subashchandrabose, et al.
Publicado: (2023)

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
por: Aillaud, Isabelle, et al.
Publicado: (2022)

GSK-3 and Tau: A Key Duet in Alzheimer’s Disease
por: Sayas, Carmen Laura, et al.
Publicado: (2021)

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
por: Šimić, Goran, et al.
Publicado: (2016)

Basic Limonoid modulates Chaperone-mediated Proteostasis and dissolve Tau fibrils
por: Gorantla, Nalini Vijay, et al.
Publicado: (2020)

Relationship between cortical iron and tau aggregation in Alzheimer’s disease
por: Spotorno, Nicola, et al.
Publicado: (2020)

Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019)

Modeling of Tau-Mediated Synaptic and Neuronal Degeneration in Alzheimer's Disease
por: Jaworski, Tomasz, et al.
Publicado: (2010)

Arrayed CRISPR reveals genetic regulators of tau aggregation, autophagy and mitochondria in Alzheimer’s disease model
por: Duan, Lishu, et al.
Publicado: (2021)

Propagation of Tau aggregates
por: Goedert, Michel, et al.
Publicado: (2017)

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
por: Kraus, Allison, et al.
Publicado: (2018)

Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer's Disease
por: Crespo-Biel, Natalia, et al.
Publicado: (2012)

Kinetics of tau aggregation reveals patient-specific tau characteristics among Alzheimer’s cases
por: Kamath, Tarun V, et al.
Publicado: (2021)

Nasal Extracts from Patients with Alzheimer’s Disease Induce Tau Aggregates in a Cellular Model of Tau Propagation
por: Pahrudin Arrozi, Aslina, et al.
Publicado: (2021)

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2022)

Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease
por: Harrington, Charles R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_843kq3h83hi105mbv1b2h4s1ks